Evidence map›Paper›PMID 41684328›Full record

ArticlemAbs2026

Balancing the extremes for antibody developability: hydrophobic and electrostatic germline framework signatures for CDR-loop compensation.

Vera A Spanke, Valentin J Egger-Hoerschinger, Clarissa A Seidler, Katharina B Kroell, Vincent Wieser, Sabine Imhof-Jung, Benjamin Weiche, Alexander Bujotzek, Guy Georges, Klaus R Liedl

Abstract read
In one paragraph

Article in mAbs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Vera A SpankeDepartment of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innsbruck, Austria.ORCID 0009-0009-3891-8101
Valentin J Egger-HoerschingerDepartment of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innsbruck, Austria.ORCID 0000-0002-4469-3238
Clarissa A SeidlerDepartment of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innsbruck, Austria.ORCID 0000-0001-7859-9234
Katharina B KroellDepartment of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innsbruck, Austria.
Vincent WieserRoche Pharma Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Penzberg, Germany.
Sabine Imhof-JungRoche Pharma Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Penzberg, Germany.
Benjamin WeicheRoche Pharma Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Penzberg, Germany.
Alexander BujotzekRoche Pharma Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Penzberg, Germany.ORCID 0000-0001-5052-0221
Guy GeorgesRoche Pharma Research and Early Development, Large Molecule Research, Roche Innovation Center Munich, Penzberg, Germany.ORCID 0000-0001-5737-006X
Klaus R LiedlDepartment of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innsbruck, Austria.ORCID 0000-0002-0985-2299

Funding

the Austrian Science Fund 10.55776/P34518
6 · The paper itself

Abstract

Antibody therapeutics are a rapidly growing class of biopharmaceuticals, but concerns regarding potential developability issues persist. While complementarity-determining region (CDR) loops are imperative for antigen specificity and mutations are challenging, the framework regions can be exchanged to align with developability attributes such as aggregation, clearance, and viscosity, all governed by physicochemical characteristics. In this study, we systematically analyze the electrostatic and hydrophobic surface properties of germline-encoded antibody frameworks to assess their role in modulating Fv developability. Using structure prediction and surface patch analysis, we identify differences between kappa and lambda light-chain frameworks, characterize outlier germlines with extreme surface properties, and demonstrate using hydrophobic interaction chromatography and a heparin column that framework selection can compensate for CDR loop physicochemical characteristics. Our findings reveal that rational framework selection can serve as a systematic tool for optimizing antibody developability. This study provides a toolbox for antibody design, enhancing therapeutic candidate selection by leveraging inherent germline properties.

Indexed as

Antibodies, MonoclonalComplementarity Determining RegionsAnimalsHumansHydrophobic and Hydrophilic InteractionsImmunoglobulin lambda-ChainsProtein EngineeringStatic ElectricityAntibodies, MonoclonalComplementarity Determining RegionsImmunoglobulin lambda-Chainsantibodydevelopabilityelectrostaticsframeworkgermlinegermline repertoirehydrophobicityin silicostructure-basedSurface patches

Identifiers

PMID41684328
PMCPMC12915817

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.